Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-29
2006-08-29
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S350000
Reexamination Certificate
active
07098182
ABSTRACT:
Novel protein antigens from Group BStreptococcusare described, together with nucleic acid sequences encoding them. Their use in vaccines and screening methods is also described.
REFERENCES:
patent: WO9410317 (1994-05-01), None
patent: WO9506732 (1995-03-01), None
patent: WO9818930 (1998-05-01), None
patent: WO9818931 (1998-05-01), None
patent: WO9823631 (1998-06-01), None
patent: WO9916882 (1999-04-01), None
patent: WO9942588 (1999-08-01), None
Larsson, Charlotte; et al., “Experimental Vaccination Against Group B Streptococcus, an Encapsulated Bacterium, with Highly Purified Preparations of Cell Surface Proteins Rib and α,”Infection and Immunity, 64:3518-3523 (1996).
Michel, James L., et al., “Cloned Alpha and Beta C-Protein Antigens of Group B Streptococci Elicit Protective Immunity,”Infection and Immunity, 59:2023-2028 (1991).
Lachenauer, Catherine S., et al., “Cloning and Expression inEscherichia coliof a Protective Surface Protein from Type V Group B Streptococci,”Advances in Experimental Medicine and Biology, 418:615-618 (1997).
Yoshida, K., et al., “Hypothetical Sensor-Like Histidine Kinase in IDH 3′ Region,” (1995) SWISS-PROT Sequence.
Tognomi, A., et al., “Peptide Synthetase 1”, (1995), SWISS-PROT Sequence.
Yoshida, K., et al., “Homologous to Many ATP-Binding Transport Proteins,” (1997), SWISS-PROT Sequence.
Puyet, A., et al., “Maltose/Maltodextrin-Binding Protein Precursor,” (1993), SWISS-PROT Sequence.
Hanniffy Sean Bosco
Le Page Richard William Falla
Wells Jeremy Mark
Hunton & Williams LLP
Microbial Technics Limited
LandOfFree
Nucleic acids and proteins from group B streptococcus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids and proteins from group B streptococcus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids and proteins from group B streptococcus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3656216